Skip to main content
. 2020 Sep 22;12:8813–8819. doi: 10.2147/CMAR.S268565

Table 2.

Comparison of Serum SF, CEA and CRP Levels Among the Three Groups

Control Group
(N=50)
Benign Group
(N=50)
Lung Cancer Group
(N=70)
F P
CEA 2.78±0.81 3.04±1.26 24.27±19.92*# 3.15 0.002
CRP 3.12±2.18 12.67±3.64*# 26.14±10.02* 4.76 0.023
SF 90.92±20.30 165.66±41.21* 244.43±97.60*# 6.89 0.034

Notes: *P<0.05 compared with the control group; #P<0.05 compared with the benign lung disease group.